Naixan



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 11.9%
Drug Use For Unknown Indication 10.2%
Langerhans' Cell Histiocytosis 10.2%
Wound Complication 10.2%
Cerebral Infarction 5.1%
Constipation 5.1%
Convulsion Prophylaxis 5.1%
Infection 5.1%
Insomnia 5.1%
Cardiovascular Insufficiency 3.4%
Fluid Replacement 3.4%
Lung Adenocarcinoma Metastatic 3.4%
Pyrexia 3.4%
Sputum Retention 3.4%
Stress Ulcer 3.4%
Tooth Abscess 3.4%
Tumour Associated Fever 3.4%
Asthma 1.7%
Gastritis 1.7%
Hepatic Function Abnormal 1.7%
Renal Failure Chronic 33.3%
Histiocytosis Haematophagic 16.7%
Bone Tuberculosis 8.3%
Hypoaesthesia 8.3%
Overdose 8.3%
Purpura Fulminans 8.3%
Sepsis 8.3%
Stevens-johnson Syndrome 8.3%
Secondary
Drug Use For Unknown Indication 16.0%
Asthma 12.0%
Anxiety 8.0%
Colon Cancer Metastatic 8.0%
Lung Neoplasm Malignant 6.0%
Anorexia 4.0%
Back Pain 4.0%
Depression 4.0%
Gastric Mucosal Lesion 4.0%
Large Intestine Carcinoma 4.0%
Nasopharyngitis 4.0%
Pain 4.0%
Pneumonia 4.0%
Product Used For Unknown Indication 4.0%
Systemic Lupus Erythematosus 4.0%
Constipation 2.0%
Diabetes Mellitus 2.0%
Febrile Neutropenia 2.0%
Gastric Ulcer 2.0%
Gastritis 2.0%
Eyelid Oedema 22.2%
Gastric Ulcer 11.1%
Gastric Ulcer Haemorrhage 11.1%
Large Intestine Perforation 11.1%
Liver Abscess 11.1%
Melaena 11.1%
Pyrexia 11.1%
Renal Failure Acute 11.1%
Concomitant
Prophylaxis 19.3%
Product Used For Unknown Indication 11.0%
Drug Use For Unknown Indication 8.3%
Juvenile Arthritis 8.1%
Cancer Pain 6.0%
Constipation 5.1%
Metastatic Renal Cell Carcinoma 4.6%
Colorectal Cancer 4.5%
Hepatic Neoplasm Malignant 4.4%
Tumour Associated Fever 4.3%
Chronic Hepatitis C 4.0%
Renal Cell Carcinoma 3.6%
Hypertension 3.5%
Rheumatoid Arthritis 2.3%
Relapsing-remitting Multiple Sclerosis 2.0%
Gastritis 1.9%
Diabetes Mellitus 1.8%
Pain 1.8%
Gastritis Prophylaxis 1.7%
Pyrexia 1.7%
Pyrexia 12.0%
Platelet Count Decreased 10.9%
Tumour Lysis Syndrome 9.7%
Rash 6.3%
Hypoproteinaemia 5.7%
White Blood Cell Count Increased 5.7%
Stomatitis 5.1%
Vomiting 4.6%
Hepatic Function Abnormal 4.0%
Pneumonia 4.0%
Renal Impairment 4.0%
White Blood Cell Count Decreased 4.0%
Interstitial Lung Disease 3.4%
Lung Disorder 3.4%
Multiple Sclerosis Relapse 3.4%
Palpitations 2.9%
Pneumothorax 2.9%
Renal Cell Carcinoma 2.9%
Weight Decreased 2.9%
Haematochezia 2.3%